LONDON MARKET CLOSE: Traders weigh war deadlock; luxury woes hit Paris
(Alliance News) - The FTSE 100 fell on Wednesday as investors awaited a hoped for resumption in peace talks between the US and Iran. Read More
| Price | 2,144.00p on 17-04-2026 at 17:35:09 |
|---|---|
| Change | 21.00p 0.99% |
| Buy | 2,138.00p |
| Sell | 2,137.00p |
| Last Trade: | Buy 2,580.00 at 2,144.00p |
| Day's Volume: | 5,135,113 |
| Last Close: | 2,144.00p |
| Open: | 2,122.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,115.00p - 2,144.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £85.64b |
| VWAP: | 2,133.88292p |
| Shares in Issue: | 3.99b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2,580 | 2,144.00p | Automatic Execution |
16:35:23 - 17-Apr-26 |
| Buy* | 2,580 | 2,144.00p | Automatic Execution |
16:35:22 - 17-Apr-26 |
| Buy* | 150 | 2,144.00p | SI Trade |
16:35:21 - 17-Apr-26 |
| Buy* | 4,798 | 2,144.00p | SI Trade |
16:35:21 - 17-Apr-26 |
| Buy* | 4,503 | 2,144.00p | SI Trade |
16:35:21 - 17-Apr-26 |
| Buy* | 159 | 2,144.00p | SI Trade |
16:35:21 - 17-Apr-26 |
| Buy* | 2,295 | 2,144.00p | Automatic Execution |
16:35:21 - 17-Apr-26 |
| Buy* | 1,779 | 2,144.00p | Automatic Execution |
16:35:21 - 17-Apr-26 |
| Buy* | 1,550 | 2,144.00p | Automatic Execution |
16:35:21 - 17-Apr-26 |
| Buy* | 10,000 | 2,144.00p | Automatic Execution |
16:35:21 - 17-Apr-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 15th Apr 2026 7:12 am | RNS | GSK completes acquisition of 35Pharma Inc. |
| 15th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 14th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 14th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 13th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 13th Apr 2026 7:00 am | RNS | GSK presents positive data for BEHOLD 1 B7 H4 ADC |
| 10th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |